Other

Dataset Information

0

Genome-wide Screening Identifies Unique Host-Directed Drugs and Pro-viral Signalling Pathways for SARS-CoV-2


ABSTRACT: SARS-CoV-2 is a positive-sense RNA virus that was responsible for the devastating COVID-19 pandemic. Although the current disease burden is less severe, there are limited treatment options, and a looming threat of the emergence of variants and future pandemics. To address these challenges, we performed genome-wide CRISPR knockout screens in a novel human lung cell line NCI-H23ACE2, as well as in HEK293TACE2 cells, with SARS-CoV-2 Wuhan strain, and identified several host-dependency factors including NRAS, KAT5, HTR3E and GNL3L. Drugs targeting some of these dependency factors, donepezil, dH-ergocristine, trametinib and sorafenib, showed effective pan-coronaviral inhibition in cell lines. Trametinib also showed inhibition of SARS-CoV-2 Delta variant in primary human airway tissue model (ALI). We also demonstrate that SARS-CoV-2 inhibits IFN-β induction through an NRAS/Raf/MEK/ERK signaling pathway dependent mechanism. Our study highlights the efficiency of a bilateral approach of gene silencing and antiviral screening to identify host-dependency factors and effective antivirals.

ORGANISM(S): Homo sapiens

PROVIDER: GSE335103 | GEO | 2026/06/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-08-06 | GSE182826 | GEO
2023-08-20 | GSE189706 | GEO
2021-03-10 | GSE159272 | GEO
2022-06-22 | GSE178699 | GEO
2026-05-08 | GSE308448 | GEO
2022-05-30 | GSE205014 | GEO
2021-04-28 | PXD024808 | Pride
2023-05-10 | PXD033342 | Pride
2024-02-16 | PXD036821 | Pride
2020-03-25 | GSE147507 | GEO